Individuals Coming Off Slimming Medications Put On Pounds at a Quadrupled Rate Compared to Dieters
Fresh analysis suggests that patients who come off blockbuster weight-loss injections like semaglutide or tirzepatide can put back on lost weight far faster than those who stop conventional diet and exercise plans.
Findings released in a prominent health publication shows that while overweight individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight returns at an average rate of nearly a kilo each month once they quit.
"People buying such drugs must be informed of the risk of fast rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.
Such speed of regain means a reversion to pre-treatment mass within about a year and a half.
Comparing Treatments
The study, which looked at dozens of studies involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.
Scientists emphasize that people who lose weight through lifestyle changes alone generally experience a less rapid creep back—approximately 100 grams monthly—once they finish.
Understanding the Quick Rebound
Nutrition scientists believe the way of the jabs is key to understanding the amplified regain.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production could lead to the system to produce less of its endogenous GLP-1, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication leads to appetite is unsuppressed, making excessive eating much more probable."
A Lifelong Issue?
Health authorities advise the injections for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, considering the likelihood of weight regain, the therapy might need to be long-term.
This opinion is echoed by drug manufacturers, who state that the results "highlight the long-term nature of obesity," akin to managing diseases like diabetes.
User Testimonies
Users who have discontinued the medication explain a intense return of hunger.
"I experienced a trigger flipping and you become ravenous," recalled an individual.
The struggle is exacerbated if individuals have not developed sustainable lifestyle or habit changes during therapy.
Growing Adoption
Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand remaining high.
- Use is greater among women compared to males.
- The middle-aged age group shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic fix and lasting health benefits hinges on combined lifestyle management.
